NGM BIOPHARMACEUTICALS INC Increase (Decrease) in Accounts Receivable, Related Parties
NGM BIOPHARMACEUTICALS INC reported Increase (Decrease) in Accounts Receivable, Related Parties of -$7.52 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2024-03-11
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable, related parties for the quarter ending 2023-12-31 was $58.00K, a 98.19% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable, related parties for the quarter ending 2023-09-30 was -$736.00K.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable, related parties for the quarter ending 2023-06-30 was -$521.00K, a 107.93% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable, related parties for the quarter ending 2023-03-31 was -$6.32M.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable, related parties for fiscal 2023 was -$7.52M, a 385.46% decline from fiscal 2022.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable, related parties for fiscal 2022 was $2.63M, a 42.87% decline from fiscal 2021.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable, related parties for fiscal 2021 was $4.61M.
- NGM BIOPHARMACEUTICALS INC increase (decrease) in accounts receivable, related parties for fiscal 2020 was -$4.87M, a 417.05% decline from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 9 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month |
|---|---|---|---|---|
| 2023-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$678.00K derived: sum of 2 quarters · filed 2024-03-11 | -$1.20M derived: sum of 3 quarters · filed 2024-03-11 | -$7.52M 10-K · filed 2024-03-11 |
| 2023-09-30 | -$736.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.26M derived: sum of 2 quarters · filed 2023-11-02 | -$7.58M 10-Q · filed 2023-11-02 | -$4.38M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-06-30 | -$521.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$6.84M 10-Q · filed 2023-08-03 | -$3.64M derived: sum of 3 quarters · filed 2024-03-11 | -$5.94M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-03-31 | -$6.32M 10-Q · filed 2023-05-04 | -$3.12M derived: sum of 2 quarters · filed 2024-03-11 | -$5.42M derived: sum of 3 quarters · filed 2024-03-11 | $1.15M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $906.00K derived: sum of 2 quarters · filed 2024-03-11 | $7.48M derived: sum of 3 quarters · filed 2024-03-11 | $2.63M 10-K · filed 2024-03-11 |
| 2022-09-30 | -$2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $4.28M derived: sum of 2 quarters · filed 2023-11-02 | -$565.00K 10-Q · filed 2023-11-02 | -$20.00K derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | $6.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.73M 10-Q · filed 2023-08-03 | $2.27M derived: sum of 3 quarters · filed 2024-03-11 | $3.09M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | -$4.84M 10-Q · filed 2023-05-04 | -$4.30M derived: sum of 2 quarters · filed 2024-03-11 | -$3.48M derived: sum of 3 quarters · filed 2024-03-11 | -$222.00K derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $1.36M derived: sum of 2 quarters · filed 2024-03-11 | $4.62M derived: sum of 3 quarters · filed 2024-03-11 | $4.61M 10-K · filed 2024-03-11 |
| 2021-09-30 | $814.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $4.08M derived: sum of 2 quarters · filed 2022-11-03 | $4.07M 10-Q · filed 2022-11-03 | -$2.81M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.25M 10-Q · filed 2022-08-04 | -$3.63M derived: sum of 3 quarters · filed 2023-02-28 | $507.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$8.00K 10-Q · filed 2022-05-05 | -$6.89M derived: sum of 2 quarters · filed 2023-02-28 | -$2.75M derived: sum of 3 quarters · filed 2023-02-28 | -$417.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$2.75M derived: sum of 2 quarters · filed 2023-02-28 | -$409.00K derived: sum of 3 quarters · filed 2023-02-28 | -$4.87M 10-K · filed 2023-02-28 |
| 2020-09-30 | $4.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $6.47M derived: sum of 2 quarters · filed 2021-11-04 | $2.01M 10-Q · filed 2021-11-04 | $7.21M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$2.13M 10-Q · filed 2021-08-05 | $3.08M derived: sum of 3 quarters · filed 2022-03-01 | $2.20M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$4.46M 10-Q · filed 2021-05-06 | $742.00K derived: sum of 2 quarters · filed 2022-03-01 | -$139.00K derived: sum of 3 quarters · filed 2022-03-01 | $742.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.33M derived: sum of 2 quarters · filed 2022-03-01 | $5.21M derived: sum of 3 quarters · filed 2022-03-01 | $1.54M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$881.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | -$3.67M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $881.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$2.79M 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | -$3.67M 10-Q · filed 2020-05-13 | |||
| 2018-12-31 | $3.67M 10-K · filed 2021-03-15 | |||
| 2017-12-31 | -$2.77M 10-K · filed 2020-03-17 |